Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

PURPOSE: This nationwide retrospective study was conducted to evaluate the efficacy and safety of combined gemcitabine and docetaxel (GD) as an off-label therapy for advanced soft tissue sarcoma, which has limited treatment options owing to its rare occurrence. MATERIALS AND METHODS: A total of 228...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yunjung, Yun, Mi Sun, Lim, Sang Hee, Lee, Jeeyun, Ahn, Jin-Hee, Kim, Yu Jung, Park, Kyong Hwa, Park, Young Suk, Lim, Ho Yeong, An, Hyonggin, Suh, Dong-Churl, Kim, Yeul Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784639/
https://www.ncbi.nlm.nih.gov/pubmed/28361521
http://dx.doi.org/10.4143/crt.2016.535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784639/
https://www.ncbi.nlm.nih.gov/pubmed/28361521
http://dx.doi.org/10.4143/crt.2016.535

Ejemplares similares